Dianthus Therapeutics 320% Year: What Investors Should Know as Stakes Shift
Dianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
This intro outlines the main advantages of a total return index, emphasizing how it reflects real returns for portfolios that reinvest dividends.
24,528 articlesDianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
Heartbreak in the headlines often carries a bigger financial signal. This piece uses the John Stamos and Rebecca Romi...
Stellantis has faced a painful setback, but a bold turnaround plan could spark renewed interest. This guide breaks do...
Climate risk scores are moving from a niche risk tool to a gatekeeper in many loan deals. This article breaks down wh...
Red Cat Holdings faced a sharp one-day re-pricing after mixed quarterly results, underscoring how revenue beats can c...
Taxing wealthy harder than it looks sounds simple: just raise rates on big earners. In practice, money moves, lawyers...
An AI alert at TIAA stopped an attempted $3 million withdrawal from a retirement portfolio, narrowly preventing a fra...
AST SpaceMobile faced a sharp weekly drop after announcing a large convertible debt raise. This article explains why ...
A high-profile venture investor steps away from ETHZilla as Ethereum treasury strategies face a new era. The move spa...
Oil spikes can move markets quickly, pushing indexes lower. Yet even with a sharp price surge, the selloff often rema...
Astera Labs has captured investor attention with a strong rally. This article dives into the reasons behind the move,...
As rates likely rise this year, stocks face a new environment. This guide breaks down what that means for the S&P 500...